Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H20FN3O3 |
| Molecular Weight | 357.3788 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C[C@@H]2C[C@H]1CN2C3=CC4=C(C=C3F)C(=O)C(=CN4C5CC5)C(O)=O
InChI
InChIKey=QMLVECGLEOSESV-RYUDHWBXSA-N
InChI=1S/C19H20FN3O3/c1-21-7-12-4-11(21)8-22(12)17-6-16-13(5-15(17)20)18(24)14(19(25)26)9-23(16)10-2-3-10/h5-6,9-12H,2-4,7-8H2,1H3,(H,25,26)/t11-,12-/m0/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 556.169
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
||
|
CFR |
21 CFR 522.522
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
||
|
WHO-VATC |
QJ01MA92
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
||
|
NCI_THESAURUS |
C795
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000083438
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
SUB06901MIG
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
DB11393
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
DANOFLOXACIN
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
112398-08-0
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
DTXSID0046432
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
6424
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
24CU1YS91D
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
C72731
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
71335
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
24CU1YS91D
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | |||
|
1358488
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | RxNorm | ||
|
m4082
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL157548
Created by
admin on Fri Dec 15 16:17:15 UTC 2023 , Edited by admin on Fri Dec 15 16:17:15 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
